Adjunct Ketamine Treatment Effects on Treatment-Resistant Depressive Symptoms in Chronic Treatment-Resistant Schizophrenia Patients Are Short-Term and Disassociated From Regional Homogeneity Changes in Key Brain Regions – A Pilot Study

Psychiatry and Clinical Psychopharmacology - United Kingdom
doi 10.1080/24750573.2019.1699726
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Clozapine in Treatment-Resistant Schizophrenia

British Journal of Psychiatry
MedicinePsychiatryMental Health
2017English

S-(+)-Ketamine-Induced Dissociative Symptoms as a Traumatic Experience in Patients With Treatment-Resistant Depression

Revista Brasileira de Psiquiatria
PsychiatryMental Health
2017English

Ketamine for Treatment-Resistant Unipolar Depression

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2012English

Mental and Physical Health Balance in Treatment-Resistant Schizophrenia

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2018English

Treatment-Resistant Major Depressive Disorder and Assisted Dying

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
2015English

Identification of Increased Genetic Risk Scores for Schizophrenia in Treatment-Resistant Patients

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2015English

Identifying and Characterizing Treatment‐resistant Schizophrenia in Observational Database Studies

International Journal of Methods in Psychiatric Research
PsychiatryMental Health
2019English

Randomized Controlled Trial of Occupational Therapy in Patients With Treatment-Resistant Schizophrenia

Revista Brasileira de Psiquiatria
PsychiatryMental Health
2003English

Cannabidiol in Patients With Treatment-Resistant Epilepsy

The Lancet Neurology
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy